Viewing Study NCT06086457


Ignite Creation Date: 2025-12-24 @ 6:48 PM
Ignite Modification Date: 2025-12-28 @ 8:27 PM
Study NCT ID: NCT06086457
Status: RECRUITING
Last Update Posted: 2024-07-16
First Post: 2023-09-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: PD-1 Inhibitor Plus Chemotherapy With or Without Radiotherapy in Patients With Metastatic Esophageal Cancer
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: BEIR 0
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER View
None OTHER View
None OTHER_GOV View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER_GOV View
None OTHER View
None OTHER View
None OTHER_GOV View